Old Mission Capital’s BioLife Solutions BLFS Stock Holding History

Old Mission Capital’s Portfolio BLFS Stock Details BLFS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-6,911	Closed	-$249K	–	1028
2021 Q1	$249K	Buy	+6,911	New	+$273K	0.01%	654

Other funds holding BLFS

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Old Mission Capital's BLFS Position: Q2 2021 in Review

Old Mission Capital sold out of BioLife Solutions (BLFS) in Q2 2021, closing a stake of 6,911 shares — an estimated $249K sold.

Old Mission Capital first reported a position in BLFS in Q1 2021 and held it in 1 quarter. The position peaked at $249K in Q1 2021. 132 funds tracked by Wall St. Rank hold BLFS as of Q2 2021.

Old Mission Capital reported no remaining BioLife Solutions position as of Q2 2021 after selling out during the quarter.
Old Mission Capital sold 6,911 BioLife Solutions shares in Q2 2021, an estimated $249K.
Old Mission Capital first reported a position in BioLife Solutions in Q1 2021 and held it in 1 quarter.
Old Mission Capital's BioLife Solutions position peaked at $249K in Q1 2021.
132 funds tracked by Wall St. Rank held BioLife Solutions as of Q2 2021.

Based on Old Mission Capital's 13F filing for Q2 2021, filed 13 Aug 2021.